Zoetis Inc Is Under The Schall Law Firm's Investigation And Investors With Losses Are Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. (...
Zoetis Inc Is Under Investigation By The Schall Law Firm And Investors Who Have Incurred Losses Are Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. (...
Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)
Zoetis stock price increased by 8.6% since last publication, underperforming S&P 500 index. Company raised full-year guidance, expecting double-digit growth, driven by DTC strategy and new products...
Zoetis (ZTS) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimate...
Zoetis Raises Guidance on Revenue Growth
Zoetis (ZTS) stock surged in intraday trading Tuesday after the company beat second-quarter revenue expectations and raised its full-year guidance.
Zoetis (ZTS) Q2 Earnings & Revenues Beat, '24 Outlook Raised
Zoetis (ZTS) reports better-than-expected Q2 results, beating both earnings and revenue estimates, primarily driven by strong sales of companion animal products. Management raises the 2024 outlook.
Why Zoetis Stock Was Moving Higher Tuesday
Zoetis beat estimates on the top and bottom lines. Both the companion animal and livestock segments delivered solid growth.
Zoetis (ZTS) Advances While Market Declines: Some Information for Investors
In the most recent trading session, Zoetis (ZTS) closed at $182.42, indicating a +1.32% shift from the previous trading day.
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note
Zoetis (ZTS) reachead $179.84 at the closing of the latest trading day, reflecting a -0.51% change compared to its last close.
Zoetis Inc Is Under Investigation By The Schall Law Firm And Investors With Losses Are Called To Contact
LOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...
Investors Of Zoetis Inc With Losses Are Encouraged To Contact As The Schall Law Firm Initiates A Probe Into Claims
LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...
Zoetis Inc Investors With Losses Are Urged To Reach Out As The Schall Law Firm Begins An Investigation Into Allegations
LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("...
Investigation Into Claims Against Zoetis Inc Is Initiated By The Schall Law Firm And Investors Who Have Suffered Losses Are Encouraged To Contact
LOS ANGELES, CA / ACCESSWIRE / July 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Z...
Zoetis Deep Dive: Better Setup Than Human Pharma
Zoetis is a leading animal pharmaceutical developer with 92% of sales from animal pharmaceuticals, over two-thirds of which are for pets. The company's competitive advantage lies in its R&D success...
Zoetis: A High-Quality Business And Fast Dividend Growth At A Reasonable Price
Zoetis is a resilient company that shows strong growth even in times of economic challenges. The company is well-positioned in a growing market and has a strong product portfolio, including a new p...
Related Companies